Physician profile
William Conte
NPI 1467794271
$1,224,777.80
in general payments reported to CMS, 2019-2025
80 companies · $276K in 2025
The $276K reported for 2025 was more than what 99% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $93K · 2020: $54K · 2021: $139K · 2022: $240K · 2023: $177K · 2024: $245K · 2025: $276K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $536K · Consulting Fee: $88K · Travel and Lodging: $49K · Food and Beverage: $26K · Education: $307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $535,787.50 |
| Consulting Fee | $87,769.50 |
| Travel and Lodging | $48,592.83 |
| Food and Beverage | $25,851.28 |
| Education | $306.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $313,345.73 | 2019-2025 | Mavenclad, Mavenclad, Evobrutinib |
| Biogen, INC. | $187,081.45 | 2019-2025 | Vumerity, Tysabri, Avonex |
| Tg Therapeutics, INC. | $127,001.67 | 2022-2025 | Briumvi |
| Genzyme Corporation | $89,278.56 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $88,542.23 | 2019-2025 | Ultomiris, Soliris, Strensiq |
| E.R. Squibb & Sons, L.L.C. | $85,688.02 | 2020-2025 | Zeposia |
| Janssen Pharmaceuticals, INC | $75,397.13 | 2020-2023 | Ponvory |
| Novartis Pharmaceuticals Corporation | $52,130.56 | 2019-2025 | |
| Genentech USA, INC. | $49,957.24 | 2019-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
| Vanda Pharmaceuticals INC. | $37,697.60 | 2024-2025 | Ponvory |
| Horizon Therapeutics Plc | $24,715.10 | 2022-2023 | Uplizna |
| F. Hoffmann-La Roche Ag | $17,923.31 | 2023 | |
| Amgen INC. | $17,654.78 | 2019-2025 | Uplizna, Evenity |
| Banner Life Sciences, LLC | $13,755.21 | 2022-2024 | |
| Celgene Corporation | $12,430.03 | 2019-2025 | Zeposia |
Show all 79 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Kgaa | $10,329.19 | 2024-2025 | |
| Abbvie INC. | $7,263.33 | 2021-2025 | Botox, Qulipta, Ubrelvy |
| Allergan, INC. | $3,115.17 | 2020-2022 | |
| Astrazeneca Pharmaceuticals Lp | $1,918.49 | 2021-2025 | Evusheld, Wainua |
| Teva Pharmaceuticals USA, INC. | $825.56 | 2019-2025 | Austedo Xr, Austedo, Ajovy |
| Lilly USA, LLC | $802.81 | 2019-2025 | Amyvid, Kisunla, Emgality |
| Jazz Pharmaceuticals INC. | $504.34 | 2019-2024 | |
| Piramal Critical Care | $435.31 | 2021-2025 | |
| Mallinckrodt Hospital Products INC. | $385.39 | 2020-2025 | Acthar |
| Pfizer INC. | $380.56 | 2023-2025 | |
| Neurocrine Biosciences, INC. | $369.69 | 2019-2025 | Ingrezza, Ongentys |
| Argenx US, INC. | $313.56 | 2023-2025 | Vyvgart Hytrulo, Vyvgart |
| Radius Health, INC. | $310.71 | 2020-2024 | Tymlos |
| Sunovion Pharmaceuticals INC. | $299.97 | 2019-2022 | |
| Ucb, INC. | $298.78 | 2019-2024 | Briviact, Nayzilam, Zilbrysq |
| Axsome Therapeutics, INC. | $286.32 | 2022-2025 | Sunosi, Symbravo |
| Acorda Therapeutics, INC | $285.98 | 2020-2024 | Ampyra, Inbrija |
| Sk Life Science, INC. | $283.46 | 2020-2025 | Xcopri |
| Lundbeck LLC | $252.21 | 2020-2024 | Rexulti, Vyepti |
| Csl Behring | $231.53 | 2019-2024 | Hizentra |
| Medtronic USA, INC. | $230.58 | 2019-2020 | |
| Eisai INC. | $225.21 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $200.76 | 2020-2021 | |
| Upsher-Smith Laboratories LLC | $175.81 | 2019-2023 | |
| Tersera Therapeutics LLC | $155.13 | 2020-2023 | Quzyttir |
| Mdd US Operations, LLC | $151.82 | 2019-2022 | |
| Amneal Pharmaceuticals LLC | $129.93 | 2019-2025 | Brekiya, Lyvispah, Lioresal (Baclofen) |
| Saol Therapeutics INC. | $117.64 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $109.53 | 2019-2025 | Hyqvia, Gammagard |
| Livanova USA, INC. | $102.07 | 2019-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Catalyst Pharmaceuticals, INC. | $97.37 | 2020-2025 | |
| Biohaven Pharmaceuticals, INC. | $97.34 | 2021 | |
| Corium, LLC | $93.62 | 2022-2023 | Adlarity |
| Cycle Pharmaceuticals INC | $92.30 | 2025 | Bafiertam, Tascenso Odt |
| Supernus Pharmaceuticals, INC. | $84.60 | 2021-2022 | |
| Neurelis, INC. | $83.46 | 2021-2025 | Valtoco |
| Biohaven Pharmaceutical Holding Company Ltd. | $81.85 | 2022 | |
| Grt US Holding, INC. | $80.67 | 2022 | |
| Acadia Pharmaceuticals INC | $71.63 | 2022-2024 | Nuplazid |
| Currax Pharmaceuticals LLC | $68.98 | 2020 | |
| Avanir Pharmaceuticals, INC. | $65.02 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $64.38 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $59.37 | 2023-2024 | Rexulti, Nuedexta |
| Abbott Laboratories | $57.04 | 2021-2024 | Infinity |
| Mallinckrodt Enterprises LLC | $55.98 | 2019 | |
| Medtronic, INC. | $54.40 | 2021-2022 | |
| Impel Pharmaceuticals INC. | $50.32 | 2022-2023 | Trudhesa |
| Avid Radiopharmaceuticals, INC. | $50.00 | 2019 | |
| Ani Pharmaceuticals, INC. | $39.04 | 2024-2025 | Purified Cortrophin Gel |
| Scilex Pharmaceuticals INC. | $35.66 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $34.44 | 2019-2020 | |
| Alvogen INC | $31.81 | 2021 | |
| Boston Scientific Corporation | $26.42 | 2025 | General - Embolics |
| Alnylam Pharmaceuticals INC. | $25.73 | 2022 | |
| Aucta Pharmaceuticals, INC. | $24.73 | 2025 | Motpoly Xr |
| Servier Pharmaceuticals LLC | $23.69 | 2024 | |
| Tonix Medicines, INC. | $23.64 | 2025 | Zembrace Symtouch |
| Averitas Pharma INC. | $23.39 | 2023 | Qutenza |
| Ceribell, INC. | $18.41 | 2023 | Ceribell Rapid Response Eeg |
| Sandoz INC. | $17.45 | 2023 | |
| Merz Pharmaceuticals, LLC | $15.22 | 2021 | |
| Harmony Biosciences LLC | $15.20 | 2020 | |
| Ge Healthcare | $14.27 | 2019 | |
| Sumitomo Pharma America, INC. | $10.91 | 2023 | Aptiom |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$9,666.56 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Conte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.